A gram-negative aerobic bacterium which contains an enzyme involved in the resistance to an active aminoglycoside for the treatment of nosocomial infections in humans.
Acinetobacter guillouiae has been isolated from gas-work effluent which reveals resistance to amikacin, an aminoglycoside for the treatment of nosocomial infections. It has been known to be originated from a bacterial host where naturally found in an environment and shows evidence as an ancestral species of genus Acinetobacter.
Acinetobacter guillouiae predominantly obtained from various ecosystem such as human clinical specimens, soil and water samples from various natural locations.
Acinetobacter guillouiae is implicated in nosocomial infections and an agent to cause urinary tract infections, ventilator-associated pneumonia and bacteremia in human diseases.
Species: Acinetobacter guillouiae
• Urinary tract infection